Pilot Grants address important problems in human clinical and/or translational research and require interdisciplinary or cross-institutional collaboration.
AEGIS Influenza provides a population-level view of regional influenza activity, demonstrating current spatial and temporal patterns and comparing them with historical data. AEGIS Influenza bridges the clinical and public health environments, providing clinical data to inform public health decisions as well as epidemiological context to inform clinical decisions.
View the maps, driving directions, phone numbers, and shuttle schedules for all the Harvard Catalyst institutions in a single place. No more hunting around for this vital information.
Community-Based Participatory Research (CBPR) is an emerging orientation to research which involves scientific inquiry that equitably involves both community stakeholders and investigators at all levels of the research process from design to dissemination. CBPR involves a partnership between the community and the investigator(s) where each group shares equal ownership of the process and products of research collaboration.
Community Connect to Research is a public resource that features ongoing health research in the Harvard community and provides extensive information about health topics, ongoing clinical trials, the clinical research process, and community participation in research. 
Harvard Catalyst makes research consultations available to Harvard-affiliated faculty and fellows at no cost. 
Search and browse this inventory of core facilities at Harvard and Harvard-affiliated academic healthcare institutions. This listing will grow, as more core facilities become available to Harvard Catalyst investigators.
HarvardTrials is the Harvard view of ClinicalTrials.gov. ClinicalTrials.gov, provided by the U.S. National Institutes of Health, is a registry of federally and privately supported clinical trials conducted in the United States and around the world. HarvardTrials allows you to search and browse just those clinical trials that are being conducted at Harvard and its affiliated institutions.
The Health Disparities Research Program aims to increase the prominence and impact of research on health disparities at Harvard. The program promotes new collaborative research, education, and training opportunities in the biomedical, clinical, and social sciences to address racial, ethnic, socioeconomic, and other disparities in health and health care.
The Harvard Catalyst Participant and Clinical Interaction Resources (PCIR) program allows investigators to perform cutting-edge human research and facilitates human interdisciplinary research across the broad spectrum of departments and research areas through transformation and extension of the former NIH-funded General Clinical Research Centers.
The Harvard Catalyst - Laboratory for Innovative Translational Technologies (HC-LITT) provides Harvard's basic and clinical research community with early access to enabling, leading-edge technologies. HC-LITT's 'collaborative research model' brings together a myriad of innovative technologies in one place, putting them in the hands of biomedical investigators from diverse disciplines.
The Petrie-Flom Center at Harvard Law School is dedicated to interdisciplinary research and debate of cutting-edge issues in health law policy, biotechnology, and bioethics. 
The Harvard Interfaculty Initiative on Medications and Society is a collaborative effort to bring together faculty and students across all Departments and Schools of Harvard University who share an interest in how prescription drugs are developed, approved, regulated, and paid for; as well as how they are prescribed, viewed, and taken by patients.
The Pathology Specimen Locator (PSL) is a distributed database indexing millions of discarded human specimens that can be used for translational studies such as biomarker discovery and validation. Investigators use PSL to locate paraffin and frozen specimens available across the Harvard pathology departments. When specimens matching the study criteria are located, investigators can request tissue and pathology services.
SHRINE, or Shared Health Research Information Network, is a peer-to-peer network of clinical databases that is being developed and will launch in the second quarter of 2009. An authorized investigator can use the Query Aggregation Interface to simultaneously send queries to multiple health care centers, without the need for a Harvard Catalyst-wide central data warehouse. 
Webdash is a tool that enables you to instantly share any web page with anyone in your address book. For example, with Webdash you can annotate published papers on the web, share that with your colleagues, and start a discussion.
The Harvard Catalyst Provider & Health Systems Research Program helps investigators plan and conduct research based on collaborations with Massachusetts-based health plans, including access to defined populations and data resources; and community practice settings, including practice-based research networks and Harvard-affiliated health care delivery systems.
- Harvard Catalyst awards its second round of pilot grants
| Full story - Request the resources of five Human Research Center sites with one form
| Full story - Harvard Catalyst adds three new consulting programs
| Full story - The web pages of the Harvard Catalyst consulting programs have moved
| Full story - Launching eagle-i: A national consortium for revealing hidden scientific resources
| Full story - Visit Harvard Catalyst at the FAS Digital Social Science Fair
| Full story
New Laboratory Accelerates Research into the Clinical Setting
The Harvard Catalyst Laboratory for Innovative Translational Technologies (HC-LITT) will put a myriad of innovative technologies in the hands of clinical and translational researchers. Temporarily, it will be located in New Research Building-3rd floor but will relocate to its permanent home, the Harvard Institutes of Medicine, in July, 2009. The lab will be a one-stop resource center featuring the newest and most powerful industry and Harvard community technologies. It will also be a forum for bringing together a potent mix of biomedical researchers, clinicians, bioinformaticians, physical scientists, and engineers using integrated, interdisciplinary approaches in solving challenging clinical problems.
To assist translational researchers, the HC-LITT will focus on:
- New Technology: providing investigators with access to diverse translational technologies ranging from sample preparation to measuring protein-small molecule interactions;
- Interdisciplinary Collaboration: providing an open environment for brainstorming new approaches to tackling problems that can only be solved with new technologies;
- Analytical Consulting: providing computational guidance related to the novel technologies in conjunction with the Harvard Catalyst Biostatistical Consulting Program.
HC-LITT will also engage in specific projects that adapt/modify new assays/technologies with the aim that they are able to become core technologies: user friendly, cheap, and clinically robust. HC-LITT will strive to develop these technologies so that other programs can offer these services to the translational community at large.
The HC-LITT will be fully open for investigator use by July, 2009.
Contact Winston Patrick Kuo, Director of Harvard Catalyst Laboratory for Innovative Translational Technologies for more information.